Similar articles for PMID: 29051345

Year	Number of Results
1999	1
2003	1
2004	1
2005	1
2007	3
2008	2
2010	3
2011	6
2012	2
2013	7
2014	7
2015	14
2016	15
2017	27
2018	27
2019	17
2020	9
2021	6
2022	4
2023	4
2024	0

1

Reply: Using and Interpreting ¹⁸F-FDG PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil Is in the Details.

Birnie D, Ohira H, Beanlands R. Birnie D, et al. J Nucl Med. 2017 Dec;58(12):2040. doi: 10.2967/jnumed.117.198226. Epub 2017 Oct 19. J Nucl Med. 2017. PMID: 29051345 Free article. No abstract available.

2

Using and Interpreting ¹⁸F-FDG PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil Is in the Details.

Lu Y, Patel DC, Sweiss N. Lu Y, et al. J Nucl Med. 2017 Dec;58(12):2039. doi: 10.2967/jnumed.117.197004. Epub 2017 Jun 29. J Nucl Med. 2017. PMID: 28663194 Free article. No abstract available.

3

Inter- and Intraobserver Agreement of ¹⁸F-FDG PET/CT Image Interpretation in Patients Referred for Assessment of Cardiac Sarcoidosis.

Ohira H, Ardle BM, deKemp RA, Nery P, Juneau D, Renaud JM, Klein R, Clarkin O, MacDonald K, Leung E, Nair G, Beanlands R, Birnie D. Ohira H, et al. J Nucl Med. 2017 Aug;58(8):1324-1329. doi: 10.2967/jnumed.116.187203. Epub 2017 Mar 2. J Nucl Med. 2017. PMID: 28254873 Free article.

4

Prognostic Impact of FDG-PET/CT Images in Patients With Suspected Cardiac Sarcoidosis: Optimal Patient Preparation, Not Complex Unconventional Analytics, Is Key to Meaningful Data.

Lu Y, Sweiss NJ, Macapinlac HA. Lu Y, et al. JACC Cardiovasc Imaging. 2019 Jan;12(1):217-219. doi: 10.1016/j.jcmg.2018.10.022. JACC Cardiovasc Imaging. 2019. PMID: 30621993 Free article. No abstract available.

5

¹⁸F-FDG/¹³N-ammonia cardiac PET findings in ATTR cardiac amyloidosis.

Young KA, Lyle M, Rosenbaum AN, Chang IC, Lin G, Bois MC, Ezzeddine OFA, Jouni H, Chareonthaitawee P, Kapa S, Grogan M, Cooper LT, Blauwet L, Bois JP. Young KA, et al. J Nucl Cardiol. 2023 Apr;30(2):726-735. doi: 10.1007/s12350-021-02886-2. Epub 2022 Jan 27. J Nucl Cardiol. 2023. PMID: 35084701

6

Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.

Ito K, Morooka M, Okazaki O, Minaminoto R, Kubota K, Hiroe M. Ito K, et al. Clin Nucl Med. 2013 Feb;38(2):128-30. doi: 10.1097/RLU.0b013e318266cb25. Clin Nucl Med. 2013. PMID: 23334129

7

Serial FDG-PET/CT Imaging in the Management of Cardiac Sarcoidosis.

Bremer W, Sweiss NJ, Lu Y. Bremer W, et al. Clin Nucl Med. 2018 Feb;43(2):e50-e52. doi: 10.1097/RLU.0000000000001919. Clin Nucl Med. 2018. PMID: 29215412

8

F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.

Simonen P, Lehtonen J, Kandolin R, Schildt J, Marjasuo S, Miettinen H, Airaksinen J, Vihinen T, Tuohinen S, Haataja P, Kupari M. Simonen P, et al. Am J Cardiol. 2015 Nov 15;116(10):1581-5. doi: 10.1016/j.amjcard.2015.08.025. Epub 2015 Sep 3. Am J Cardiol. 2015. PMID: 26411357

9

(18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.

Skali H, Schulman AR, Dorbala S. Skali H, et al. Curr Cardiol Rep. 2013 May;15(5):352. doi: 10.1007/s11886-013-0352-8. Curr Cardiol Rep. 2013. PMID: 23504346 Review.

10

How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body ¹⁸F-fluorodeoxyglucose positron emission tomography.

Juneau D, Nery P, Russo J, de Kemp RA, Leung E, Beanlands RSB, Birnie DH. Juneau D, et al. Int J Cardiol. 2018 Feb 15;253:189-193. doi: 10.1016/j.ijcard.2017.09.204. Int J Cardiol. 2018. PMID: 29306462 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

124 results

Results by year